• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CARDIOVASCULAR SYSTEMS CORP. TERUMO ADVANCED PERFUSION SYSTEM 1; CONSOLE, HEART-LUNG MACHINE, CARDIOPULMONARY BYPASS-ADVANCED PERFUSION SYSTEM 1

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CARDIOVASCULAR SYSTEMS CORP. TERUMO ADVANCED PERFUSION SYSTEM 1; CONSOLE, HEART-LUNG MACHINE, CARDIOPULMONARY BYPASS-ADVANCED PERFUSION SYSTEM 1 Back to Search Results
Model Number 801074
Device Problem Out-Of-Box Failure (2311)
Patient Problem No Patient Involvement (2645)
Event Date 01/28/2016
Event Type  malfunction  
Manufacturer Narrative
(b)(4).This complaint is related to mdr #1828100-2015-00808.The srt reported the voltage from the o2 sensor with 100% oxygen was 1.879 volts direct current (vdc), which is within specification.With the blender setpoint at 80% the central control monitor (ccm) reported 82.5%, the external o2 analyzer showed the actual o2 as 76.5%, which is outside the +/- 3% acceptance specification.The srt installed a new o2 sensor and ran applicable phase 2 tests.The unit operated to manufacturer specifications and was returned to clinical use.During the laboratory evaluation, a lab-use only (luo) epgs was within specifications for o2% with the returned o2 sensor installed.The product surveillance technician (pst) installed the returned o2 sensor into a luo epgs and connected the epgs to a system-1 simulator and ccm.He connected the epgs to oxygen and air, entered a perfusion screen on the ccm.After the 15 minute warm-up period, calibration of the o2 sensor was initiated and passed.The measurement of the direct current (d/c) output voltage from the o2 sensor at 5 liters per minute (l/min) and 100% o2 was 1.81 volts which is within the specification of 0.55-2.758 volts.The pst set the test epgs at 5 l/min and 80% o2.The ccm displayed 79.4% and an external o2 meter displayed 79.8%.Also tested the o2 sensor at 21%, 50% and 100%.Nothing was observed that would cause failure.
 
Event Description
The service repair technician (srt) reported that during routine testing of the device at the service center, the electronic patient gas system (epgs) failed the oxygen (o2) sensor reading accuracy portion of the verification test.There was no patient involvement.
 
Manufacturer Narrative
The reported complaint was confirmed.If additional information becomes available on this complaint that would alter the facts and/or conclusion, a supplemental report will be filed accordingly.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TERUMO ADVANCED PERFUSION SYSTEM 1
Type of Device
CONSOLE, HEART-LUNG MACHINE, CARDIOPULMONARY BYPASS-ADVANCED PERFUSION SYSTEM 1
Manufacturer (Section D)
TERUMO CARDIOVASCULAR SYSTEMS CORP.
6200 jackson road
ann arbor MI 48103
Manufacturer Contact
jan winder
6200 jackson road
ann arbor, MI 48103
7346634145
MDR Report Key5444346
MDR Text Key38997740
Report Number1828100-2016-00094
Device Sequence Number1
Product Code DTQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K022947
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 04/19/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date05/12/2016
Device Model Number801074
Device Catalogue Number801074
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/29/2016
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 01/28/2016
Initial Date FDA Received02/18/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received04/19/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/13/2016
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
-
-